We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Test for Mad Cow Disease

By HospiMedica staff writers
Posted on 27 Apr 2004
A new rapid test for bovine spongiform encephalopathy (BSE), also known as mad cow disease, has been cleared by the U.S. More...
Food and Drug Administration (FDA).

The test, which detects the presence of the abnormal prions believed to cause BSE, was developed by Enfer Scientific, Ltd. (Newbridge, Ireland). The company entered into a marketing and distribution agreement in 2001 with Abbott Laboratories (Abbott Park, IL, USA), which gave the Abbott exclusive rights to sell the test throughout the world except in Ireland. The test has been approved for cattle testing in the European Union and Japan. The rapid test provides results within hours, is easy to use, and meets the workflow needs of the screening laboratories approved by the United States Department of Agriculture (USDA).

"The rapid Enfer BSE assay tests every bovine brain sample in duplicate,” said Jim Koziarz, Ph.D., vice president, research and development, diagnostics, Abbot Laboratories. "If either test result is reactive, the brain specimen is resampled and retested in duplicate. This type of testing method ensures that a true positive would be reliably detected.”

Enfer Scientific is the world's largest screening laboratory for transmissible spongiform encephalopathies (TSEs) using the Enfer test. The company routinely performs up to 9,000 tests per day, providing results to beef processors within a minimum turnaround time of 12 hours. Prior to the approval of rapid BSE tests, the USDA used an immunohistochemistry BSE test that took several days to perform and report the results.


Related Links:
Enfer Scientific
Abbott Labs

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.